Clinical trial

To Determine if There Are Pharmacokinetic Interactions at Plasma or…

NCT00335192 · Germans Trias i Pujol Hospital, Other · Completed

Key facts

NCT number NCT00335192
Title To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
Official title Determination of Plasma and Intracellular Levels of Nucleoside Reverse Transcriptase Inhibitors (NRTI) and of Nucleotide Analog Tenofovir Disoproxil Fumarate (TDF) in Patients Treated With Abacavir and/or Lamivudine Given With or Without TDF.
Lead sponsor Germans Trias i Pujol Hospital, Other
Collaborators Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Status Completed
Phase Phase 4
Study type Interventional
Conditions HIV
Intervention type Drug
Interventions Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks, Patients in treatment with ABV + TDF + LPV/rtv, Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks
Enrollment 32
Start date Jan 1, 2005
Primary completion Sep 1, 2005
Completion Sep 1, 2005
First posted Jun 9, 2006
Last update posted Sep 8, 2008
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies